Efficacy and safety of SARS-CoV-2 neutralizing antibody, SCTA01, in high-risk outpatients diagnosed with COVID-19: A Phase II clinical trial

Authors

Institutions

Publication Details

Journal
Contemporary Clinical Trials Communications
Published
2025-05-17
DOI
https://doi.org/10.1016/j.conctc.2025.101496
Citations
1
Primary Topic
SARS-CoV-2 and COVID-19 Research
Type
article
Field-Weighted Citation Impact
1.40

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Efficacy and safety of SARS-CoV-2 neutralizing antibody, SCTA01, in high-risk outpatients diagnosed with COVID-19: A Phase II clinical trial

Liangzhi Xie, Allex Jardim da Fonseca, Dongfang Liu, Lixin Yan et al.
1 citations
Contemporary Clinical Trials Communications
SARS-CoV-2 and COVID-19 Research
1.40
article

Efficacy and safety of SARS-CoV-2 neutralizing antibody, SCTA01, in high-risk outpatients diagnosed with COVID-19: A Phase II clinical trial

Liangzhi Xie, Allex Jardim da Fonseca, Dongfang Liu, Lixin Yan, Jorge Díaz
article en
1 citations

Abstract

No abstract available for this paper.
Contemporary Clinical Trials CommunicationsVol. 45
Chinese Academy of Medical Sciences & Peking Union Medical College (CN), Sinocelltech Group (China) (CN), Sino Biological (China) (CN), Universidade Estadual de Roraima (BR), Universidade Federal de Roraima (BR), Millennia Atlantic University (US)
National Key Research and Development Program of China, Beijing Science and Technology Planning Project
Good health and well-being
Openalex Percentile: Top 21%
SARS-CoV-2 and COVID-19 Research
1.40
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.